glp-1 gastroparesis lawsuit in kentucky Trulicity [2026] glp-1 gastroparesis law office in

UPDATE: Added FAQs in the comments section

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk

These medications can cause a rollercoaster of side effects at different stages of treatment

Low FODMAP

Comfort Support: The specialized probiotic Akkermansia muciniphila may help maintain healthy gut flora